Pegvisomant therapy in acromegalic patient resistant to other treatment: case report
Introduction: Acromegaly is a chronic, rare disorder resulting from growth hormone (GH) hypersecretion, usually caused by a pituitary adenoma. GH stimulates synthesis of insulin-like growth factor 1 (IGF-1), whom assay should be used as a screening test whenever acromegaly is suspected. Patients wit...
Saved in:
Main Authors: | Emilia Nowicka (Author), Michał Obel (Author), Piotr Dzikowski (Author), Martyna Stefaniak (Author), Zofia Pietrzak (Author), Ewa Obel (Author) |
---|---|
Format: | Book |
Published: |
Kazimierz Wielki University,
2022-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Complex treatment of invasive corticotropic pituitary macroadenoma - Case report
by: Michał Obel, et al.
Published: (2022) -
Efficacy and safety of fenfluramine in the treatment of Dravet syndrome - literature review
by: Martyna Stefaniak, et al.
Published: (2022) -
Eslicarbazepine acetate: An efficacy and safety as an antiepileptic drug in clinical trials and open studies
by: Martyna Stefaniak, et al.
Published: (2022) -
Safety and efficacy of cenobamate in patients with uncontrolled focal seizures - a review of the literature
by: Zofia Pietrzak, et al.
Published: (2022) -
Outcome Melatonin Supplementation on Insulin Resistance in a Sample of Iraqi Acromegalic Patients with Sleep Apnea
by: Yusr abdulkarim Hamid, et al.
Published: (2019)